Skip to main content
. 2019 Oct 18;27(2):284–293. doi: 10.1093/jamia/ocz188

Table 4.

Application of time complexity data

Findings Summary
Drug-Route Dyad Complexity Score Mean (seconds) SD (seconds) Resources Utilized Per Verified Order
Senna PO low 2.9 6 0
Atorvastatin PO low 3.1 4.3 0.2
Aspirin PO low 6.5 9.3 0.43
Cefazolin IV low 19.4 22.9 1
Dexamethasone IV moderate 14 14.8 0.3
Piperacillin-tazobactam IV moderate 33.4 26.2 1.37
Fentanyl IV high 13.7 16.3 0.17
Amiodarone IV high 15.3 18.9 0.53
Norepinephrine IV high 19.8 22.5 0.33
Morphine IV high 25.5 31.3 1.03
Amount of Time Saved with Low Complexity Group
Drug-Route Dyad Mean (seconds) Annualized Volume of Orders Time Saved per Year (Sec; hours) Time Saved per Month (Sec; hours)
Senna PO 2.9 37 062 107 480; 29.85 8957; 2.49
Atorvastatin PO 3.1 11 220 34 782; 9.7 2899; 0.81
Aspirin PO 6.5 23 580 153 270; 42.58 12 773; 3.55
Cefazolin IV 19.4 21 132 409 960; 113.88 34 163; 9.49
Totala 31.9 92 994 705 492; 196.01 58 791; 16.33
a

Mean-12.5, volume-71 862, Time/year-295 532; 82.1, Time/month-24 627.67; 6.84 if cefazolin totals excluded.